<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dwyer</surname>
    <given-names>J. J.</given-names>
   </name>
   <name>
    <surname>Wilson</surname>
    <given-names>K. L.</given-names>
   </name>
   <name>
    <surname>Davison</surname>
    <given-names>D. K.</given-names>
   </name>
   <name>
    <surname>Freel</surname>
    <given-names>S. A.</given-names>
   </name>
   <name>
    <surname>Seedorff</surname>
    <given-names>J. E.</given-names>
   </name>
   <name>
    <surname>Wring</surname>
    <given-names>S. A.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2007</year>). 
  <article-title>Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.</article-title>
  <source>
   <italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
  </source>
  <volume>104</volume>
  <fpage>12772</fpage>â€“
  <lpage>12777</lpage>. 
  <pub-id pub-id-type="doi">10.1073/pnas.0701478104</pub-id>
  <pub-id pub-id-type="pmid">17640899</pub-id>
 </mixed-citation>
</ref>
